Lixte Biotechnology (NASDAQ:LIXT – Get Rating) is one of 941 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Lixte Biotechnology to related companies based on the strength of its institutional ownership, valuation, earnings, analyst recommendations, dividends, risk and profitability. Analyst Ratings This is […]